演講嘉賓

Aimee Jackson, PhD

Founder

Jackson Bioscience Consulting

Alain Deschênes

Vice President

Chemical Computing Group

Ali Nahvi, Ph.D

Chief Technology Officer

Nava Therapeutics

Amy Druschitz

Technical Business Development Manager

Croda Pharma

Anastasia Khvorova, PhD

Professor, RNA Therapeutics Institute

UMass Chan Medical School

Anders Lund, PhD

Senior Scientist

Aldevron

Andreas Kuhn, PhD

Senior Vice President RNA Biochemistry & CMC Development

BioNTech SE

Andrew Bockus

Director of Chemistry

Circle Pharma, Inc

Andrew Geall, PhD

Co-founder and Chief Development Officer

Replicate Bioscience

Andrew Livingston

Chief Executive Officer

Exactmer

Andrzej Dziembowski

Head of the Laboratory of RNA Biology

Int'l Institute of Molecular & Cell Biology

Anthony Person, Ph.D

Director of Business Development, CELLSCRIPT™

CELLSCRIPT™

Ari Friedland

Vice President of Research

Typewriter Therapeutics

Art Krieg, MD

CEO

Zola Therapeutics

Asaf Cohen

SVP, CMC and Operations

Splisense

Dr. Ashok Bhandari, PhD

Executive Vice President, Chief Discovery Officer

Protagonist Therapeutics

Beatriz De La Torre, Ph.D.

Research Professor, Laboratory of Medicine and Med

University Of KwaZulu-Natal

Beatriz Llamusi, PhD

Chief Scientific Officer & Co-Founder

Arthex Biotech

Ben Kleinstiver, PhD

Associate Professor

Massachusetts General Hospital & Harvard Medical School

Dr. Benjamin Andreone, PhD

Associate Director, Neuroscience

Atalanta Therapeutics

Bharath Venkatram

Senior Engineer, Process Development & Scale Up Lab

Amgen

Bradley Pentelute, PhD

Professor, Chemistry

Massachusetts Institute of Technology

C. J. Venkatramani, PhD

Distinguished Scientist

Genentech

Caleb Culy

Senior Principal Chemist, Process Design and Development

Eli Lilly and Company

Carolyn Mazzitelli, PhD

Executive Director

Ionis Pharmaceuticals

Cecilia Fernández, Ph.D.

Entrepreneur in Residence

Mass General Brigham Ventures

Chandra Vargeese, PhD

Chief Technology Officer

Wave Life Science

Charles Allerson, Ph.D

Chief Technology Officer

Switch Therapeutics

Charles Johannes, PhD

Founder & President & Chief Scientist

EPOC Scientific LLC

Christoph Schmoelzer

Head of Product Management, Advanced Therapies

Thermo Fisher Scientific

Chunping Xu, Ph.D

Senior Director of Chemistry R&D

TriLink BioTechnologies

Craig Grant

Vice President and General Manager Cambridge

Veranova

Dr Cristina Bertulli, PhD

Vice President of Business

Exactmer Ltd

Dr. Dan Tardiff, PhD

Chief Scientific Officer

CAMP4 Therapeutics

Daniel Blessing

Chief Technology Officer & Scientific Co-Founder

HAYA Therapeutics

Daniel Chu

Process Development Manager

Kinovate Life Sciences

David Butler, PhD

Chief Technology Officer

Hongene Biotech Corporation

David De Lucrezia, PhD

Vice President and General Manager

TriLink Technologies

David Entwistle, PhD

Senior Director, Program & Pipeline Management

Codexis

David Guay, PhD

VP Innovation & Technology

Feldan Therapeutics

David Vodak, PhD

Chief Scientific Officer

Bend Bioscience

Derek Gauntlett

Vice President, Development

Codexis

Derek O'Flaherty, Ph.D

Assistant Professor

University of Guelph

Devan Shah

Founder & Chief Executive Officer

RNAV8 Bio

Dr. Dong-Eun Kim, PhD

Professor, Department of Bioscience and Biotechnology

Konkuk University

Eckhard Jankowsky, PhD

mRNA Scientist

NewCo

Eivor Örnskov, Ph.D.

Principal Scientist, Pharmaceutical Sciences

AstraZeneca Gothenburg

Elissa Hobert, PhD

Director of Discovery Technologies

NewCo

Ella Meyer

Lead of RNA Synthesis

EnPlusOne Bio

Emel Adaligil, PhD

Executive Director, Chemical Biology and Peptide

Eli Lilly and Company

Emily Guinn, PhD

Senior Engineering Advisory

Eli Lilly and Company

Eric Kool, Ph.D

Professor of Chemistry

Stanford University

Erina Kamiya

Business Development, Life Industry Division

Inabata America Corporation

Felix Schumacher

Program Leader Targeted Therapeutics

Roche

Fernando Albericio, Ph.D

Research Professor

University of Kwazulu-Natal

Firoz Antia, PhD

Vice President, Oligonucleotide & Small Molecule CMC

Denali Therapeutics

Dr. Fouad Atouf, PhD

Executive Vice President, and Chief Science Officer

US Pharmacopeia

Fran Wincott, PhD

President

Wincott & Associates, LLC

Frank DeRosa, PhD

Chief Technology Officer & Global Head of Research, mRNA Center of Excellence

Sanofi

G. Susan Srivatsa, PhD

President

ElixinPharma

Gary Musso, PhD

President

Musso and Associates LLC

Genwei Zhang, PhD

Head of Peptide Research

XtalPi

Gerard Platenburg, PhD

Chief Scientific Officer

ProQR Therapeutics

Greg Hoffman, PhD

Chief Scientific Officer

Deep Genomics

Guillaume Jacquot, PhD

Program Director, Brain and Tissue Delivery of Oligonucleotides

Vect-Horus

Hadi Fares, PhD

Senior Scientist

DuPont Water Solutions

Hagen Cramer, PhD

Chief Technology Officer

QurAlis

Hannes Stärk

PhD Student, CSAIL

MIT

Dr. Hassan Fakih, PhD

Post-Doctoral Associate

UMass Chan Medical School

Dr. Hien Zhao, PhD

Vice President, Neuroscience Research

Ionis Pharmaceuticals

Hiroki Serizawa

Process Chemist

Chugai Pharma Manufacturing Co., Ltd.

Jace Jones, PhD

Associate Professor and Vice Chair for Education Associate Director of the Mass Spectrometry Center Department of Pharmaceutical Sciences

University of Maryland School of Pharmacy

James Powell

SVP, Manufacturing and Boulder Site Head

Novo Nordisk

Jane Wang, PhD

VP and Head of Delivery and Process Devlopment

Tessera Therapeutics

Jefferson Revell, PhD

Principal Scientist

AstraZeneca

Jennifer Franklin

Executive Director, CMC Regulatory Affairs

Ionis Pharmaceuticals

Jill Caswell, PhD

Biology Team Leader

Almac Sciences

Jim Weterings, PhD

Vice President , Head of Oligonucleotide Therapeutics

Bonito Biosciences

Dr. Jingjun Yin, PhD

Executive Director

Merck Research Laboratories

Joanna Hemming Taylor, PhD

Associate Principal Scientist

AstraZeneca

Dr. Joe Lewcock, PhD

Chief Scientific Officer

Denali Therapeutics

John McGee

Scientific Co-Founder and Senior Vice President, Platform Technology

Parabilis Medicines

John Zuris, PhD

Principal

John Zuris Consulting LLC

Joo-Sung Yang

VP and Head of the New Therapeutics Business Development

Samyang Biopharm

Joshua Brooks, PhD

Director, Process Sciences

Alnylam Pharmaceuticals

Judy Carmody, Ph.D.

Founder and Principal Consultant

Carmody Quality Solutions, LLC

Dr. Judy Walker, PhD

Chief Medical Officer

Arthex Biotech

Dr. Julia Alterman, Ph.D.

Assistant Professor, RNA Therapeutics Institute

University of Massachusetts Chan Medical

Karl Dane Wittrup, Ph.D.

C.P. Dubbs Professor in Chemical Engineering and Biological Engineering

Massachusetts Institute of Technology

Dr. Katharine (Katie) Duncan, PhD

Director, CMC Policy and Advocacy

GlaxoSmithKline (GSK)

Katherine Buzecky

Director of Scientific Services

Fluid Air

Kathryn Ackley, PhD

CMC Consultant Specializing in Oligonucleotides

Independent Consultant

Dr. Kayal Madhivanan, PhD

Senior Scientist

Arrowhead Pharmaceuticals

Kevin Seibert, PhD

Vice President, Engineering, Synthetic Molecule Design and Development

Eli Lilly and Company

Dr. Kiran Musunuru, MD, PhD

Barry J. Gertz Professor for Translational Research, Perelman School of Medicine

University of Pennsylvania

Kristine McKinney, Ph.D

Vice President and Head, Cancer Vaccines Research

Moderna

Kurt Vagle

Senior Director - Chemical Development RNAi CMC

Novo Nordisk

Kurt Vesterager Gothelf, Ph.D.

Professor, Department of Chemistry and iNANO

Aarhus University

Kyler Lugo, Ph.D

Principal Scientist

Nosis Bio

Laura Sepp-Lorenzino, PhD

Biotech Executive, Board Member and Industry Advisor

GNMmeds LLC

Levi Knippel, Ph.D

Senior Scientist

Merck

Ligang Zhang, PhD

Vice President, DS Process Development

Alnylam Pharmaceuticals

Dr. Lin Wang, PhD

Director, Analytical CMC

Gilead Sciences

Linda Burkly

Executive Vice President & Chief Scientific Office

Editas Medicine

Liqun Wang, PhD

Principal Scientist, Brain Targeting Program

Wyss Institute at Harvard University

Loic Vincent, PhD

Chief Scientific Officer

Korro Bio

Lori Troup

Director of Analytical Development

Dicerna/Novo Nordisk

Louis Diorazio, PhD

Senior Principal Scientist, New Modalities

AstraZeneca

Lucas Siow

CEO and Co-Founder

ProteinQure

Mangala Soundar

VP Biology

Judo Bio

Marc Abrams, PhD

Chief Technology Officer & Head, US Operations

SanegeneBio

Marc Jacob, PhD

Head of Strategic Development, Chromatography Products

YMC America

Dr. Marian Kupculak, PhD

Co-Founder and Chief Science Officer

Sensible Biotechnologies

Mr Mark Dickman

Professor

University of Sheffield

Mark Karmarz, Ph.D

Executive Director of Biologics Development

Tallac Therapeutics

Maryke Fehlau

CTO

BioNukleo

Matteo Villain, PhD

Vice President of Peptide and Oligonucleotide

Veranova

Meena PhD

SVP, Translational DMPK and Clinical Pharmacology

Stoke Therapeutics

Melissa Vasbinder, Ph.D

Head of Research

Mariana Oncology

Michael Booth

Associate Professor of Chemical Biology and Organic Chemistry

University College London

Michael Kopach, PhD

Associate Vice President, Synthetic Molecule Design and Development

Eli Lilly and Company

Mikael Andersson Schönn

Senior Application Scientist

Bio-Works

Mike Webb, Ph.D.

Founder and CEO

Mike Webb Pharma

Mimoun Ayoub, PhD

Senior VP, Global Head of Peptide and Oligonucleotide Platforms

CordenPharma International

Dr. Mridula Dogra, PhD

Director

Eli Lilly and Company

Muthiah (Mano) Manoharan, PhD

Senior Vice President of Drug Innovation and Distinguished Research Scientist

Alnylam Pharmaceuticals

Neha Kaushal, Ph.D

Associate Director, Research and Biomarkers

Sanofi mRNA Center of Excellence

Olivier Ludemann-Hombourger, PhD

Director, Global Innovation and Technology

PolyPeptide Group

Oron Yacoby Zevi

Chief Scientific Officer

Immunobel Therapeutics

Dr. Pablo Lores Lareo, PhD

CMC Director

Sylentis

Padma Akkapeddi, PhD

Senior Scientist, Discovery Sciences

Denali Therapeutics

Pedro Gautier

Director of Process Validation

Agilent Technologies

Peter Korytko, Ph.D.

President

Preclinical GPS

Dr. Pierce Ogden, PhD

Co-Founder, CTO and Board Director

Manifold Bio

Dr. Piers Gaffney, PhD

Chief Scientific Officer & VP of Research

Exactmer

Pin-Nan Cheng, Ph.D

Sr Dir, Drug Substance Development, CMC

Altimmune

Punit Seth, PhD

SVP, Research

Alnylam Pharmaceuticals

Dr. Rachel Johns, PhD

Executive Director, Analytical Development, Formulations, QC

Avidity Biosciences

Robert Britton

Professor

Simon Fraser University

Robert Langer, ScD

David H. Koch Institute Professor

Massachusetts Institute of Technology

Roberto Profeta

R&D Manager

F.I.S. Fabbrica Italiana Sintetici

Ms. Roxana Eggleston-Rangel

Advanced Workflows Applications Manager

Phenomenex

Rubina Parmar,

PhD

Atlas Ventures

Sabine Fenner

Director Oligo R&D

Bachem

Sakya Mohapatra

Director, Formulation Development

Recode Therapeutics

Sarah Lovelock, Ph.D.

Reader in Biological Chemistry

University of Manchester

Saul Martinez Montero

Senior Director and Head of Oligonucleotide Therapeutics

Dyne Therapeutics

Dr. Sean Kevlahan, PhD

Co-founder and CEO

Nanite

Seb Caille, PhD

Senior Director

Avidity Biosciences

Seth Alexander, PhD

Director of RNA Technologies

Prime Medicine

Shayak Samaddar, Ph.D

Senior Advisor, Drug Product Formulation

Eli Lilly & Company

Dr. Sonja Merkas, PhD

Founder, Creator and Doer

Livinovea

Stefan Hyde

Automation Manager

Asahi Kasei Bioprocess America

Dr. Stefan Lutz, PhD

Chief Scientific Officer

Codexis

Dr. Stefano Zanotti, PhD

SVP, Head of Neuromuscular Research

Dyne Therapeutics

Stephen Spagnol, PhD

Director, Enabling Technologies

Merck

Steven Wolk, PhD

President

Sinawali Biotechnology Solutions

Dr. Stéphane Roche, PhD

Founder and CEO

AdaptBio Therapeutics

Sudhir Agrawal

President and Founder

Arnay Sciences

Susan Li, PhD

Peptide Chief Scientist

Asymchem

Sven Warhaut, PhD

Vice Head of Manufacturing

BioSpring GmbH

Takaki Habuchi, PhD

Research Associate

Nippon Shokubai

Telmo Graça, PhD

Head of mRNA Process Development

Lonza

Thomas Vrucina

Deputy Head Liposome Technology

Polymun Scientific

Tomi Sawyer, PhD

Chief Medicinal Chemistry & Peptide Drug Hunter, Courage Terapeutics; Chief Drug Hunter & President

Maestro Therapeutics

Toshifumi Kano

Research Associate

Sumitomo Chemical Europe

Trishul Shah, M.S.

Global Sales and Marketing (interim), Head of Sales, Americas

PolyPeptide Laboratories Inc.

Troels Koch, PhD

CTO & Scientific Advisor

NewCo

Uyanga Tsedev

Founder & Chief Scientific Officer

Gensaic

Vadim Dudkin, PhD

Founding Chief Technology Officer

Soufflé Therapeutics

Vasant Jadhav, PhD

Chief Technology Officer

Alnylam Pharmaceuticals

Ved Srivastava, PhD

CTO

Perpetual Medicines

Vikram Mulligan, PhD

Research Scientist

Flatiron Institute

Viorel Simion, Ph.D

Director of Immunology

Sail Biomedicines

Walter Pebley

Chief Science Officer

OFD Life Sciences

Wayne Doyle

Head of Platform

Eclipse Bioinnovations

Wuming Yan

Chief Scientist Oligonucleotides

Asymchem

Xiao Zhou

Senior Scientist

Biogen

Yannick Fillon, PhD

Product Technical Lead, Oligonucleotides

Biogen

Yansheng Wu

Vice President, Global Head of CMC & Regulatory

Hongene Biotech Corporation, USA

Yogesh Sanghvi, PhD

President

Rasayan Inc.

Yoshitaka Nemoto

Vice President R&D

PeptiStar

Zdravka Medarova, PhD

Co-Founder and Chief Scientific Officer

TransCode Therapeutics

Zhichao Zhang, Ph.D

Advisor, Bioproduct Research and Development

Eli Lilly & Company

Jale Muslehiddinoglu, PhD

Vice President of Strategic Innovation

ST Pharm

Kris Choi

Senior Vice President, Marketing and Business Development

ST Pharm

Marco Minuth, PhD

Director Oligo R&D II

Bachem

Alexander Kleinsmann, PhD

Director R&D, CMC Development

Bachem AG

Dr. Qiuheng Jin

R&D Director

Vazyme Biotech

Dr Cole Seifert, PhD

Research & Technology Specialist

Croda Pharma